DISTINCT PHARMACOLOGICAL PROPERTIES AND DISTRIBUTION IN NEURONS AND ENDOCRINE-CELLS OF 2 ISOFORMS OF THE HUMAN VESICULAR MONOAMINE TRANSPORTER

Citation
Jd. Erickson et al., DISTINCT PHARMACOLOGICAL PROPERTIES AND DISTRIBUTION IN NEURONS AND ENDOCRINE-CELLS OF 2 ISOFORMS OF THE HUMAN VESICULAR MONOAMINE TRANSPORTER, Proceedings of the National Academy of Sciences of the United Statesof America, 93(10), 1996, pp. 5166-5171
Citations number
44
Categorie Soggetti
Multidisciplinary Sciences
ISSN journal
00278424
Volume
93
Issue
10
Year of publication
1996
Pages
5166 - 5171
Database
ISI
SICI code
0027-8424(1996)93:10<5166:DPPADI>2.0.ZU;2-#
Abstract
A second isoform of the human vesicular monoamine transporter (hVMAT) has been cloned from a pheochromocytoma cDNA library. The contribution of the two transporter isoforms to monoamine storage in human neuroen docrine tissues was examined with isoform-specific polyclonal antibodi es against hVMAT1 and hVMAT2. Central, peripheral, and enteric neurons express only VMAT2. VMAT1 is expressed exclusively in neuroendocrine, including chromaffin and enterochromaffin, cells. VMAT1 and VMAT2 are coexpressed in all chromaffin cells of the adrenal medulla. VMAT2 alo ne is expressed in histamine storing enterochromaffin-like cells of th e oxyntic mucosa of the stomach. The transport characteristics and pha rmacology of each VMAT isoform have been directly compared after expre ssion in digitonin-permeabilized fibroblastic (CV-1) cells, providing information about substrate feature recognition by each transporter an d the role of vesicular monoamine storage in the mechanism of action o f psychopharmacologic and neurotoxic agents in human. Serotonin has a similar affinity for both transporters. Catecholamines exhibit a 3-fol d higher affinity, and histamine exhibits a 30-fold higher affinity, f or VMAT2. Reserpine and ketanserin are slightly more potent inhibitors of VMAT2-mediated transport than of VMAT1-mediated transport, whereas tetrabenazine binds to and inhibits only VMAT2. N-methyl-4-phenylpyri dinium, phenylethylamine, amphetamine, and methylenedioxymethamphetami ne are all more potent inhibitors of VMAT2 than of VMAT1, whereas fenf luramine is a more potent inhibitor of VMAT1-mediated monamine transpo rt than of VMAT2-mediated monoamine transport. The unique distribution s of hVMAT1 and hVMAT2 provide new markers for multiple neuroendocrine lineages, and examination of their transport properties provides mech anistic insights into the pharmacology and physiology of amine storage in cardiovascular, endocrine, and central nervous system function.